Publications by authors named "Andrew Pink"

Claim this Profile
D
Development of a psoriatic arthritis - like presentation under anti - IL-13 therapy with tralokinumab for atopic dermatitis.
Katya Meridor, Sook Yan Lee, Ilona Blee, Jane E Freeston, Philip M Laws, Andrew Pink

Rheumatology (Oxford)· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Rapid improvement of itch with nemolizumab in atopic dermatitis and prurigo nodularis phase 3 studies.
Sonja Ständer, Sarina B Elmariah, Shawn G Kwatra, Gil Yosipovitch, Andrew E Pink

J Eur Acad Dermatol Venereol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nemolizumab in prurigo nodularis up to 100 weeks: OLYMPIA LTE interim analysis.
Franz J Legat, Shawn G Kwatra, Adam Reich, Serge Boulinguez, Athanasios Tsianakas, Andrew E Pink

J Eur Acad Dermatol Venereol· December 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
M
Mendelian randomization identifies OX40 as a potential mediator of the effects of cigarette smoking on palmoplantar pustulosis.
Alice Smail, Nick Dand, Xinyue Liu, , David Baudry, Andrew E Pink

Br J Dermatol· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
O
Oral Icotrokinra for Plaque Psoriasis in Adults and Adolescents.
Robert Bissonnette, Jennifer Soung, Adelaide A Hebert, Andrew E Pink, Andreas Pinter

N Engl J Med· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and safety of rocatinlimab for the treatment of moderate-to-severe atopic dermatitis in ROCKET-IGNITE and ROCKET-HORIZON: two global, double-blind, placebo-controlled, randomised phase 3 clinical trials.
Emma Guttman-Yassky, Kenji Kabashima, Margitta Worm, Paula C Luna, H Chih-Ho Hong, Andrew E Pink

Lancet· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient Experiences on the Diagnosis, Management, and Burden of Generalized Pustular Psoriasis: An International Web Survey and Qualitative Interview Study.
Mark Lebwohl, Hideki Fujita, Kilian Eyerich, Andrew E Pink, Min Zheng

J Psoriasis Psoriatic Arthritis· November 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
PLAN-psoriasis: protocol for a randomised controlled feasibility trial comparing patient-led 'as-needed' treatment and therapeutic drug monitoring-guided treatment to continuous treatment for adults with clear or almost clear skin on risankizumab monotherapy for psoriasis.
Weiyu Ye, Kingsley Powell, Niamh Dooley, Charlotte M Thomas, Bola Coker, Andrew E Pink

BMJ Open· October 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Personalizing Biologic Therapy in Psoriasis: Development, Validation, and User Testing of a Precision-Dosing Dashboard.
Charlotte M Thomas, David Baudry, Zehra Arkir, Bola Coker, Tejus Dasandi, Andrew Pink

J Invest Dermatol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Response to Lavin et al (2025)'s Paper: Cutaneous T-Cell Lymphoma after Dupilumab Use: A Real-World Pharmacovigilance Study of the FDA Adverse Event Reporting System.
Mariel L James, Andrew E Pink, Richard T Woolf, Patrick Batty, Satveer Mahil

J Invest Dermatol· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
Achieving Optimal Treatment Targets and Minimal Disease Activity with Upadacitinib for Moderate-to-Severe Atopic Dermatitis: Integrated Analysis of Phase 3 Studies (Measure Up 1 and 2).
Jonathan I Silverberg, Melinda Gooderham, Norito Katoh, Valeria Aoki, Andrew E Pink

Dermatol Ther (Heidelb)· September 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of Achieving Optimal Treatment Targets and Minimal Disease Activity on Health-Related Quality of Life and Satisfaction in Patients with Atopic Dermatitis.
Jonathan I Silverberg, Melinda Gooderham, Andreas Wollenberg, Andrew E Pink, Diego Ruiz Dasilva

Dermatol Ther (Heidelb)· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
J
Janus kinase inhibitors in palmoplantar pustulosis: a mixed-methods feasibility (JAKPPPOT) trial protocol.
David Gleeson, Sarah Chapman, Helen McAteer, April Qin, John Gregory, Andrew E Pink

BMJ Open· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Safety of tralokinumab in patients with moderate-to-severe atopic dermatitis followed for up to 4.5 years: an integrated analysis of 8 clinical trials.
Kristian Reich, Richard G Langley, Juan Francisco Silvestre Salvador, Delphine Staumont-Sallé, Antonio Costanzo, Andrew E Pink

Br J Dermatol· August 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
F
FRONTIER-2: A phase 2b, long-term extension, dose-ranging study of oral JNJ-77242113 for the treatment of moderate-to-severe plaque psoriasis.
Laura K Ferris, Jerry Bagel, Yu-Huei Huang, Andrew E Pink, Stephen K Tyring

J Am Acad Dermatol· March 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Efficacy and Safety of Nemolizumab in Patients With Moderate to Severe Prurigo Nodularis: The OLYMPIA 1 Randomized Clinical Phase 3 Trial.
Sonja Ständer, Gil Yosipovitch, Franz J Legat, Adam Reich, Carle Paul, Andrew Pink

JAMA Dermatol· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
S
Switching from Dupilumab to Abrocitinib in Patients With Moderate-to-Severe Atopic Dermatitis: A Post Hoc Analysis of Efficacy After Treatment With Dupilumab in JADE DARE.
Jonathan I Silverberg, Eric L Simpson, Andrew E Pink, Stephan Weidinger, Gary Chan

Dermatol Ther (Heidelb)· February 2025

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Combining treat-to-target principles and shared decision-making: International expert consensus-based recommendations with a novel concept for minimal disease activity criteria in atopic dermatitis.
Jonathan I Silverberg, Melinda Gooderham, Norito Katoh, Valeria Aoki, Andrew E Pink

J Eur Acad Dermatol Venereol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
A
An expert consensus on managing dupilumab-related ocular surface disorders in people with atopic dermatitis 2024.
Michael R Ardern-Jones, Sara J Brown, Carsten Flohr, Parwez Hossain, Alan D Irvine, Andrew E Pink

Br J Dermatol· November 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
N
Nemolizumab with concomitant topical therapy in adolescents and adults with moderate-to-severe atopic dermatitis (ARCADIA 1 and ARCADIA 2): results from two replicate, double-blind, randomised controlled phase 3 trials.
Jonathan I Silverberg, Andreas Wollenberg, Adam Reich, Diamant Thaçi, Franz J Legat, Andrew E Pink

Lancet· August 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
D
Dupilumab in chronic actinic dermatitis: a retrospective case series.
Marese O'Reilly, Alexandra Paolino, Pirunthan Pathmarajah, John Ferguson, Catherine H Smith, Andrew E Pink

Br J Dermatol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
International Consensus Definition and Diagnostic Criteria for Generalized Pustular Psoriasis From the International Psoriasis Council.
Siew Eng Choon, Peter van de Kerkhof, Johann E Gudjonsson, Claudia de la Cruz, Jonathan Barker, Andrew Pink

JAMA Dermatol· July 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
C
Clinical course, treatment and management of generalised pustular psoriasis from a United Kingdom extension of a global Delphi panel.
Jonathan N Barker, Gabrielle Becher, David A Burden, Andrew E Pink, Maria Zacharioudaki

Skin Health Dis· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
P
Patient-reported burden in adults with atopic dermatitis: an international qualitative study.
Andreas Wollenberg, Melinda Gooderham, Norito Katoh, Valeria Aoki, Andrew E Pink

Arch Dermatol Res· June 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
U
Upadacitinib Rapidly Improves Patient-Reported Outcomes in Atopic Dermatitis: 16-Week Results from Phase 3 Clinical Trials (Measure Up 1 and 2).
Eric L Simpson, Vimal H Prajapati, Yael A Leshem, Raj Chovatiya, Marjolein S de Bruin-Weller, Andrew E Pink

Dermatol Ther (Heidelb)· May 2024

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis